Literature DB >> 22058231

A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models.

Tyler J VanderWeele1, Stijn Vansteelandt.   

Abstract

Estimates of additive interaction from case-control data are often obtained by logistic regression; such models can also be used to adjust for covariates. This approach to estimating additive interaction has come under some criticism because of possible misspecification of the logistic model: If the underlying model is linear, the logistic model will be misspecified. The authors propose an inverse probability of treatment weighting approach to causal effects and additive interaction in case-control studies. Under the assumption of no unmeasured confounding, the approach amounts to fitting a marginal structural linear odds model. The approach allows for the estimation of measures of additive interaction between dichotomous exposures, such as the relative excess risk due to interaction, using case-control data without having to rely on modeling assumptions for the outcome conditional on the exposures and covariates. Rather than using conditional models for the outcome, models are instead specified for the exposures conditional on the covariates. The approach is illustrated by assessing additive interaction between genetic and environmental factors using data from a case-control study.

Mesh:

Year:  2011        PMID: 22058231      PMCID: PMC3246690          DOI: 10.1093/aje/kwr334

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  22 in total

1.  Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Authors:  David P Miller; Geoffrey Liu; Immaculata De Vivo; Thomas J Lynch; John C Wain; Li Su; David C Christiani
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Interaction as departure from additivity in case-control studies: a cautionary note.

Authors:  Anders Skrondal
Journal:  Am J Epidemiol       Date:  2003-08-01       Impact factor: 4.897

4.  Confidence interval estimation of interaction.

Authors:  D W Hosmer; S Lemeshow
Journal:  Epidemiology       Date:  1992-09       Impact factor: 4.822

5.  Estimating the relative excess risk due to interaction: a bayesian approach.

Authors:  Haitao Chu; Lei Nie; Stephen R Cole
Journal:  Epidemiology       Date:  2011-03       Impact factor: 4.822

6.  Confidence intervals for measures of interaction.

Authors:  S F Assmann; D W Hosmer; S Lemeshow; K A Mundt
Journal:  Epidemiology       Date:  1996-05       Impact factor: 4.822

7.  Synergism and interaction: are they equivalent?

Authors:  W J Blot; N E Day
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

8.  Additive risk versus additive relative risk models.

Authors:  S Greenland
Journal:  Epidemiology       Date:  1993-01       Impact factor: 4.822

9.  Concepts of interaction.

Authors:  K J Rothman; S Greenland; A M Walker
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

10.  Interaction and synergism.

Authors:  R Saracci
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

View more
  18 in total

1.  Recommendations for presenting analyses of effect modification and interaction.

Authors:  Mirjam J Knol; Tyler J VanderWeele
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  A mapping between interactions and interference: implications for vaccine trials.

Authors:  Tyler J VanderWeele; Jan P Vandenbroucke; Eric J Tchetgen Tchetgen; James M Robins
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

3.  Invited Commentary: The Continuing Need for the Sufficient Cause Model Today.

Authors:  Tyler J VanderWeele
Journal:  Am J Epidemiol       Date:  2017-06-01       Impact factor: 4.897

4.  Invited commentary: assessing mechanistic interaction between coinfecting pathogens for diarrheal disease.

Authors:  Tyler J Vanderweele
Journal:  Am J Epidemiol       Date:  2012-07-25       Impact factor: 4.897

5.  Invited commentary: Some advantages of the relative excess risk due to interaction (RERI)--towards better estimators of additive interaction.

Authors:  Tyler J VanderWeele; Stijn Vansteelandt
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

6.  Rose and van der Laan respond to "Some advantages of the relative excess risk due to interaction".

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

7.  A double robust approach to causal effects in case-control studies.

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

Review 8.  Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus.

Authors:  Dodie L Arnold; Daniel A Enquobahrie; Chungfang Qiu; Jonathan Huang; Nancy Grote; Ann VanderStoep; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2015-03-23       Impact factor: 3.980

9.  A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors.

Authors:  Jian Gong; Carolyn Hutter; John A Baron; Sonja Berndt; Bette Caan; Peter T Campbell; Graham Casey; Andrew T Chan; Michelle Cotterchio; Charles S Fuchs; Steven Gallinger; Edward Giovannucci; Tabitha Harrison; Richard Hayes; Li Hsu; Shuo Jiao; Yi Lin; Noralane M Lindor; Polly Newcomb; Bethann Pflugeisen; Amanda I Phipps; Thomas Rohan; Robert Schoen; Daniela Seminara; Martha L Slattery; Deanna Stelling; Fridtjof Thomas; Greg Warnick; Emily White; John Potter; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-20       Impact factor: 4.254

10.  Reconsidering the denominator of the attributable proportion for interaction.

Authors:  Tyler J VanderWeele
Journal:  Eur J Epidemiol       Date:  2013-09-14       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.